Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All antihistamine H1RA studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchAntihistamine H1RAsH1RAs (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Chlorpheniramine Maleate Displays Multiple Modes of Antiviral Action Against SARS-CoV-2: A Mechanistic Study

Elshaier et al., bioRxiv, doi:10.1101/2023.08.28.554806
Aug 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
10th treatment shown to reduce risk in December 2020
 
*, now with p = 0.00006 from 15 studies.
Lower risk for mortality, recovery, and cases.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,700+ studies for 94 treatments. c19early.org
In Vitro study showing that chlorpheniramine maleate (CPM) inhibits SARS-CoV-2 infection by affecting viral adsorption, replication, and having a direct virucidal effect in Vero E6 cells. Molecular docking analysis revealed that CPM interacts with essential SARS-CoV-2 proteins, including the main protease receptor, spike protein receptor, and RNA polymerase, primarily through hydrophobic interactions and an additional hydrogen bond in the RNA polymerase active site. Authors suggest CPM has potential as a multitarget antiviral agent against SARS-CoV-2 and potentially other respiratory viruses.
12 preclinical studies support the efficacy of antihistamine H1RAs for COVID-19:
Elshaier et al., 29 Aug 2023, USA, preprint, 6 authors. Contact: rahaghf@ccf.org.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperH1RAsAll
Chlorpheniramine Maleate Displays Multiple Modes of Antiviral Action Against SARS-CoV-2: A Mechanistic Study
Yaseen A M M Elshaier, Ahmed Mostafa, Fernando Valerio-Pascua, Mari L Tesch, Joshua M Costin, M.D, M.H.S Franck F Rahaghi
Chlorpheniramine Maleate (CPM) has been identified as a potential antiviral compound against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In this study, we investigated the in vitro effects of CPM on key stages of the SARS-CoV-2 replication cycle, including viral adsorption, replication inhibition, and virucidal activity. Our findings demonstrate that CPM exhibits antiviral properties by interfering with viral adsorption, replication, and directly inactivating the virus. Molecular docking analysis revealed interactions between CPM and essential viral proteins, such as the main protease receptor, spike protein receptor, and RNA polymerase. CPM's interactions were primarily hydrophobic in nature, with an additional hydrogen bond formation in the RNA polymerase active site. These results suggest that CPM has the potential to serve as a multitarget antiviral agent against SARS-CoV-2 and potentially other respiratory viruses. Further investigations are warranted to explore its clinical implications and assess its efficacy in vivo.
References
Ahmad, Pawara, Surana, Patel, The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19, Top Curr Chem (Cham)
Allam, Assaf, Hassan, Shimizu, Elshaier, An in silico perception for newly isolated flavonoids from peach fruit as privileged avenue for a countermeasure outbreak of COVID-19 [10.1039/D0RA05265E, RSC Advances, doi:10.1039/D0RA05265E
Black, Molecular Modeling and Preliminary Clinical Data Suggesting Antiviral Activity for Chlorpheniramine (Chlorphenamine) Against COVID-19, Cureus, doi:10.7759/cureus.20980
Blanco, Bonilla, Homma, Suzuki, Fremont-Smith et al., Antihistamines and azithromycin as a treatment for COVID-19 on primary health care -A retrospective observational study in elderly patients, Pulm Pharmacol Ther, doi:10.1016/j.pupt.2021.101989
Feoktistova, Geserick, Leverkus, Crystal Violet Assay for Determining Viability of Cultured Cells, Cold Spring Harb Protoc, doi:10.1101/pdb
Gies, Bekaddour, Dieudonné, Guffroy, Frenger et al., Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine, Front Immunol, doi:10.3389/fimmu.2020.01409
Jabeen, Pleban, Rinner, Chiba, Ecker, Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein, J Med Chem, doi:10.1021/jm201705f
Jin, Du, Xu, Deng, Liu et al., Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors, Nature, doi:10.1038/s41586-020-2223-y
Jin, Du, Xu, Deng, Liu et al., Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors, Nature, doi:10.1038/s41586-020-2223-y
Kandeil, Mostafa, El-Shesheny, Shehata, Roshdy et al., Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt, Microbiol Resour Announc
Kuo, Lin, Tsai, Chou, Kung et al., Samarangenin B from Limonium sinense suppresses herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis, Antimicrob Agents Chemother, doi:10.1128/aac.46.9.2854-2864.2002
Lee, Kofonow, Rosen, Siebert, Chen et al., Bitter and sweet taste receptors regulate human upper respiratory innate immunity, Drug Discov Today Technol, doi:10.1172/jci72094Ligandefficiencyasaguidein
Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, doi:10.1016/0022-1759(83)90303-4
Mostafa, Kandeil, Kutkat, Moatasim, Rashad et al., FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2, Pharmaceuticals, doi:10.3390/ph13120443
Mostafa, Kandeil, Shehata, El Shesheny, Samy et al., Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science, Microorganisms
Reznikov, Norris, Vashisht, Bluhm, Li et al., Identification of antiviral antihistamines for COVID-19 repurposing, Biochem Biophys Res Commun, doi:10.1016/j.bbrc.2020.11.095
Rizvi, Ferrer, Khawaja, Sanchez-Gonzalez, Chlorpheniramine, an Old Drug with New Potential Clinical Applications: A Comprehensive Review of the Literature, Current Reviews in Clinical and Experimental Pharmacology, doi:10.2174/2772432817666220601162006
Sanchez-Gonzalez, Rizvi, Torres, Ferrer, A Randomized Controlled Pilot Trial to Test the Efficacy of Intranasal Chlorpheniramine Maleate With Xylitol for the Treatment of Allergic Rhinitis, Cureus, doi:10.7759/cureus.14206
Sanchez-Gonzalez, Westover, Rizvi, Torres, Ferrer, Intranasal Chlorpheniramine Maleate for the treatment of COVID-19: Translational and Clinical Evidence, Medical Research Archives, doi:10.18103/mra.v10i3.2752
Schuhmacher, Reichling, Schnitzler, Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro, Phytomedicine, doi:10.1078/094471103322331467
Torres, Go, Camacho, Sanchez-Gonzalez, Ferrer, Chlorpheniramine Maleate Nasal Spray In COVID-19 Patients: Case Series, J Clin Exp Pharmacol, doi:10.35248/2161-1459.21.10.275
Towler, Staker, Prasad, Menon, Tang et al., ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis, J Biol Chem
Valerio-Pascua, Mejia, Tesch, Godoy, Fuentes et al., Chlorpheniramine Intranasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: The ACCROS Trials
Westover, Ferrer, Vazquez, Bethencourt-Mirabal, Go, In Vitro Virucidal Effect of Intranasally Delivered Chlorpheniramine Maleate Compound Against Severe Acute Respiratory Syndrome Coronavirus 2, Cureus, doi:10.7759/cureus.10501
Wrapp, Wang, Corbett, Goldsmith, Hsieh et al., Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, doi:10.1126/science
Xu, Xia, Pu, Wang, Li et al., The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses, Front Microbiol, doi:10.3389/fmicb.2018.02643
Zhang, Zhan, Yao, Gao, Shong, Antiviral activity of tannin from the pericarp of Punica granatum L. against genital Herpes virus in vitro, Zhongguo Zhong Yao Za Zhi
{ 'institution': [{'name': 'bioRxiv'}], 'indexed': {'date-parts': [[2023, 9, 3]], 'date-time': '2023-09-03T08:46:53Z', 'timestamp': 1693730813526}, 'posted': {'date-parts': [[2023, 8, 29]]}, 'group-title': 'Pharmacology and Toxicology', 'reference-count': 28, 'publisher': 'Cold Spring Harbor Laboratory', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'accepted': {'date-parts': [[2023, 8, 29]]}, 'abstract': '<jats:title>Abstract</jats:title><jats:p>Chlorpheniramine Maleate (CPM) has been identified ' 'as a potential antiviral compound against Severe Acute Respiratory Syndrome Coronavirus 2 ' '(SARS-CoV-2). In this study, we investigated the in vitro effects of CPM on key stages of the ' 'SARS-CoV-2 replication cycle, including viral adsorption, replication inhibition, and ' 'virucidal activity. Our findings demonstrate that CPM exhibits antiviral properties by ' 'interfering with viral adsorption, replication, and directly inactivating the virus. ' 'Molecular docking analysis revealed interactions between CPM and essential viral proteins, ' 'such as the main protease receptor, spike protein receptor, and RNA polymerase. CPM’s ' 'interactions were primarily hydrophobic in nature, with an additional hydrogen bond formation ' 'in the RNA polymerase active site. These results suggest that CPM has the potential to serve ' 'as a multitarget antiviral agent against SARS-CoV-2 and potentially other respiratory ' 'viruses. Further investigations are warranted to explore its clinical implications and assess ' 'its efficacy in vivo.</jats:p>', 'DOI': '10.1101/2023.08.28.554806', 'type': 'posted-content', 'created': {'date-parts': [[2023, 8, 30]], 'date-time': '2023-08-30T04:05:15Z', 'timestamp': 1693368315000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Chlorpheniramine Maleate Displays Multiple Modes of Antiviral Action Against SARS-CoV-2: A ' 'Mechanistic Study', 'prefix': '10.1101', 'author': [ {'given': 'Yaseen A. M. M.', 'family': 'Elshaier', 'sequence': 'first', 'affiliation': []}, {'given': 'Ahmed', 'family': 'Mostafa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fernando', 'family': 'Valerio-Pascua', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7216-4352', 'authenticated-orcid': False, 'given': 'Mari L.', 'family': 'Tesch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joshua M.', 'family': 'Costin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Franck F.', 'family': 'Rahaghi', 'sequence': 'additional', 'affiliation': []}], 'member': '246', 'reference': [ { 'key': '2023090207500473000_2023.08.28.554806v1.1', 'doi-asserted-by': 'crossref', 'first-page': '40', 'DOI': '10.1007/s41061-021-00353-7', 'article-title': 'The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19', 'volume': '379', 'year': '2021', 'journal-title': 'Top Curr Chem (Cham)'}, { 'key': '2023090207500473000_2023.08.28.554806v1.2', 'doi-asserted-by': 'publisher', 'DOI': '10.1039/D0RA05265E'}, { 'key': '2023090207500473000_2023.08.28.554806v1.3', 'doi-asserted-by': 'publisher', 'DOI': '10.7759/cureus.20980'}, { 'key': '2023090207500473000_2023.08.28.554806v1.4', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/pdb.prot087379'}, { 'key': '2023090207500473000_2023.08.28.554806v1.5', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fimmu.2020.01409'}, { 'key': '2023090207500473000_2023.08.28.554806v1.6', 'doi-asserted-by': 'publisher', 'DOI': '10.1021/jm201705f'}, { 'key': '2023090207500473000_2023.08.28.554806v1.7', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-020-2223-y'}, { 'key': '2023090207500473000_2023.08.28.554806v1.8', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-020-2223-y'}, { 'key': '2023090207500473000_2023.08.28.554806v1.9', 'doi-asserted-by': 'crossref', 'unstructured': 'Kandeil, A. , Mostafa, A. , El-Shesheny, R. , Shehata, M. , Roshdy, W.H. ' ', Ahmed, S.S. , Gomaa, M. , Taweel, A.E. , Kayed, A.E. , Mahmoud, S.H. , ' 'Moatasim, Y. , Kutkat, O. , Kamel, M.N. , Mahrous, N. , Sayes, M.E. , ' 'Guindy, N.M.E. , Naguib, A. , and Ali, M.A. (2020). Coding-Complete ' 'Genome Sequences of Two SARS-CoV-2 Isolates from Egypt. Microbiol Resour ' 'Announc 9.', 'DOI': '10.1128/MRA.00489-20'}, { 'key': '2023090207500473000_2023.08.28.554806v1.10', 'doi-asserted-by': 'publisher', 'DOI': '10.1128/AAC.46.9.2854-2864.2002'}, { 'key': '2023090207500473000_2023.08.28.554806v1.11', 'doi-asserted-by': 'publisher', 'DOI': '10.1172/JCI72094'}, { 'key': '2023090207500473000_2023.08.28.554806v1.12', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ddtec.2010.11.003'}, { 'key': '2023090207500473000_2023.08.28.554806v1.13', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.pupt.2021.101989'}, { 'key': '2023090207500473000_2023.08.28.554806v1.14', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/0022-1759(83)90303-4'}, { 'issue': '7', 'key': '2023090207500473000_2023.08.28.554806v1.15', 'doi-asserted-by': 'crossref', 'first-page': '991', 'DOI': '10.3390/microorganisms8070991', 'article-title': 'Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the ' 'Science', 'volume': '8', 'year': '2020', 'journal-title': 'Microorganisms'}, { 'key': '2023090207500473000_2023.08.28.554806v1.16', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ph13120443'}, { 'key': '2023090207500473000_2023.08.28.554806v1.17', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.bbrc.2020.11.095'}, { 'key': '2023090207500473000_2023.08.28.554806v1.18', 'doi-asserted-by': 'publisher', 'DOI': '10.2174/2772432817666220601162006'}, { 'key': '2023090207500473000_2023.08.28.554806v1.19', 'doi-asserted-by': 'publisher', 'DOI': '10.7759/cureus.14206'}, { 'key': '2023090207500473000_2023.08.28.554806v1.20', 'doi-asserted-by': 'publisher', 'DOI': '10.18103/mra.v10i3.2752'}, { 'key': '2023090207500473000_2023.08.28.554806v1.21', 'doi-asserted-by': 'publisher', 'DOI': '10.1078/094471103322331467'}, { 'key': '2023090207500473000_2023.08.28.554806v1.22', 'doi-asserted-by': 'publisher', 'DOI': '10.35248/2161-1459.21.10.275'}, { 'key': '2023090207500473000_2023.08.28.554806v1.23', 'doi-asserted-by': 'publisher', 'DOI': '10.1074/jbc.M311191200'}, { 'key': '2023090207500473000_2023.08.28.554806v1.24', 'doi-asserted-by': 'crossref', 'unstructured': 'Valerio-Pascua, F. , Mejia, E.J.P. , Tesch, M. , Godoy, J. , Fuentes, ' 'C.L. , Erazo, G. , Bermúdez, M. , Pineda, M.F.V. , Rivzi, S.a.A. , ' 'Cabrera, A. , Chauhan, Z. , Grullón-Franco, S. , Paulino-Then, J. , ' 'Garcia, N. , Williams, J. , and Rahaghi, F. (2022). “Chlorpheniramine ' 'Intranasal Spray to Accelerate COVID-19 Clinical Recovery in an ' 'Outpatient Setting: The ACCROS Trials”. Research Square).', 'DOI': '10.21203/rs.3.rs-2167465/v1'}, { 'key': '2023090207500473000_2023.08.28.554806v1.25', 'doi-asserted-by': 'publisher', 'DOI': '10.7759/cureus.10501'}, { 'key': '2023090207500473000_2023.08.28.554806v1.26', 'doi-asserted-by': 'publisher', 'DOI': '10.1126/science.abb2507'}, { 'key': '2023090207500473000_2023.08.28.554806v1.27', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fmicb.2018.02643'}, { 'issue': '9', 'key': '2023090207500473000_2023.08.28.554806v1.28', 'first-page': '556', 'article-title': '[Antiviral activity of tannin from the pericarp of Punica granatum L. ' 'against genital Herpes virus in vitro]', 'volume': '20', 'year': '1995', 'journal-title': 'Zhongguo Zhong Yao Za Zhi'}], 'container-title': [], 'original-title': [], 'link': [ { 'URL': 'https://syndication.highwire.org/content/doi/10.1101/2023.08.28.554806', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 9, 2]], 'date-time': '2023-09-02T14:50:16Z', 'timestamp': 1693666216000}, 'score': 1, 'resource': {'primary': {'URL': 'http://biorxiv.org/lookup/doi/10.1101/2023.08.28.554806'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2023, 8, 29]]}, 'references-count': 28, 'URL': 'http://dx.doi.org/10.1101/2023.08.28.554806', 'relation': {}, 'subject': [], 'published': {'date-parts': [[2023, 8, 29]]}, 'subtype': 'preprint'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit